Skip to content

Research for effect and mechanism of HanTangping VS Metformin treatment of newly diagnosed type 2 diabetes: a randomized controlled trial

Research for effect and mechanism of HanTangping VS Metformin treatment of newly diagnosed type 2 diabetes: : a randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023378
Enrollment
Unknown
Registered
2019-05-25
Start date
2019-05-29
Completion date
Unknown
Last updated
2019-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Sponsors

The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Those who meet the diagnostic criteria of Western medicine and the diagnostic criteria of TCM syndromesand: 1. Aged 18 to 60 years; 2. Diagnosed as type 2 diabetes, who had not received any hypoglycemic medication in the past and who had poor control of blood glucose after 3 months of dietary exercise or had short-term hypoglycemic medication (<1 month) and discontinued for more than 3 months. 3. Islet function is acceptable, insulin release test shows delayed insulin secretion or insulin peak / basal value = 3 (Ip / Io = 3). 4. 18kg/m2=BMI=35kg/m2. 5. Voluntary participants in the study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Although the blood glucose is higher than normal, the blood glucose test drops below the diagnostic value through the diet control and the increase in the activity during the test introduction phase. 2. Pregnancy or lactation women. 3. People who cannot take metformin. 4. Those who are allergic to traditional Chinese medicine ingredients. 5. People with serious heart, liver, kidney, brain and other complications or other serious primary diseases. 6. People with acute metabolic disorders such as diabetic ketoacidosis or co-infection in the past 1 month. 7. People who are unwilling to cooperate or mentally ill. 8. People with diabetes complications as the main symptom

Design outcomes

Primary

MeasureTime frame
Glycated hemoglobin;

Secondary

MeasureTime frame
Fasting plasma glucose;2-hour postprandial blood glucose;HOMA-ß;HOMA-IR;Area under the insulin curve;Total cholesterol;Triglyceride;High density lipoprotein cholesterol;Low density lipoprotein cholesterol;Body fat rate;Symptom grading quantization table;Fiery symptom score;Complication rate;routine blood tests;routine urinalysis;liver function;renal function;electrocardiogram;

Countries

China

Contacts

Public ContactSaimei Li

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

lisaimei2004@163.com+86 15818159018

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026